MetHealth is excited to announce the successful completion of a $3 million funding round aimed at advancing its innovative biomarker-based risk-stratification platform and AI-driven digital health solution. With obesity emerging as a critical public health challenge, MetHealth dedicates itself to transforming the landscape of preventive care by identifying high-risk patients and providing clinicians with actionable insights. This new capital will allow us to further enhance our technology, develop more comprehensive algorithms, and expand our outreach to healthcare providers who are eager to implement personalized health solutions for their patients struggling with obesity-related complications. Our platform not only supports clinical decision-making but also fosters a cohesive approach to patient care, ensuring that treatment plans are tailored to the unique needs of individuals. We envision a healthcare system where data-driven insights empower providers and improve patient outcomes through early intervention and continuous monitoring. This funding will be pivotal as we seek to scale our operations and broaden our impact, ultimately helping clinics deliver a higher standard of personalized care. We are grateful for the support from our investors who believe in our mission and look forward to leveraging these resources to bring transformative solutions to healthcare systems across the United States. With this funding, MetHealth is poised to continue its journey of innovation, enhancing patient care and helping mitigate the far-reaching implications of obesity on individuals and the healthcare system as a whole.







